164 related articles for article (PubMed ID: 9365854)
21. Clinical impact of selective spasm provocation tests: comparisons between acetylcholine and ergonovine in 1508 examinations.
Sueda S; Kohno H; Fukuda H; Ochi N; Kawada H; Hayashi Y; Uraoka T
Coron Artery Dis; 2004 Dec; 15(8):491-7. PubMed ID: 15585990
[TBL] [Abstract][Full Text] [Related]
22. [Reproducibility of the clinical, electrocardiographic and coronarographic aspects of spontaneous coronary spasm with the use of ergonovine maleate].
Bramucci E; Specchia G; De Servi S; Angoli L; Mussini A; Marinoni GP; Gavazzi A; Falcone C; Valsecchi O; Montemartini C
G Ital Cardiol; 1978 May; 8(5):489-95. PubMed ID: 669106
[TBL] [Abstract][Full Text] [Related]
23. Cimetidine induces coronary artery spasm in patients with vasospastic angina.
Shimokawa H; Okamatsu S; Taira Y; Nakamura M
Can J Cardiol; 1987 May; 3(4):177-82. PubMed ID: 3594301
[TBL] [Abstract][Full Text] [Related]
24. New combined spasm provocation test in patients with rest angina: intracoronary injection of acetylcholine after intracoronary administration of ergonovine.
Sueda S; Ochi T; Yano K; Mineoi K; Kondou T; Ochi N; Hayashi Y; Kukita H; Matsuda S; Kawada H; Tsuruoka T; Uraoka T
Jpn Circ J; 2000 Aug; 64(8):559-65. PubMed ID: 10952150
[TBL] [Abstract][Full Text] [Related]
25. [The influence of ergonovine on coronary artery diameter and hemodynamics in patients with angina pectoris at rest (author's transl)].
Bussmann WD; Klug W; Scriba U; Kaltenbach M
Z Kardiol; 1980 Jul; 69(7):478-87. PubMed ID: 6778005
[TBL] [Abstract][Full Text] [Related]
26. [Evaluation of coronary flow reserve in patients with vasospastic angina].
Anzai H; Saijo T; Nakajima R; Tezuka N; Takagi T; Tsunoda T; Kobayashi N; Nakamura S; Yamaguchi T
J Cardiol; 2000 Jul; 36(1):17-27. PubMed ID: 10929262
[TBL] [Abstract][Full Text] [Related]
27. Ergonovine-provoked esophageal spasm during coronary angiography.
Lieberman DA; Jendrzejewski JW; McAnulty JH
West J Med; 1984 Mar; 140(3):403-8. PubMed ID: 6710982
[TBL] [Abstract][Full Text] [Related]
28. Clinical implications of provocation tests for coronary artery spasm: safety, arrhythmic complications, and prognostic impact: multicentre registry study of the Japanese Coronary Spasm Association.
Takagi Y; Yasuda S; Takahashi J; Tsunoda R; Ogata Y; Seki A; Sumiyoshi T; Matsui M; Goto T; Tanabe Y; Sueda S; Sato T; Ogawa S; Kubo N; Momomura S; Ogawa H; Shimokawa H;
Eur Heart J; 2013 Jan; 34(4):258-67. PubMed ID: 22782943
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological spasm provocation testing in 2500 patients: provoked spasm incidence, complications and cardiac events.
Sueda S
Heart Vessels; 2020 Oct; 35(10):1368-1377. PubMed ID: 32350639
[TBL] [Abstract][Full Text] [Related]
30. [Does quinapril improve coronary vasoconstriction in vasospastic angina?].
Anzai H; Saijo T; Nakajima R; Tezuka N; Takagi T; Tsunoda T; Kobayashi N; Nakamura S; Yamaguchi T
J Cardiol; 2000 Dec; 36(6):379-86. PubMed ID: 11190581
[TBL] [Abstract][Full Text] [Related]
31. Correlation between arteriographic and electrocardiographic features during spasm in the left anterior descending coronary artery.
Matsubara T; Tamura Y; Yamazoe M; Hori T; Konno T; Ida T; Higuchi K; Takemoto M; Imai S; Aizawa Y
Coron Artery Dis; 1997; 8(8-9):525-35. PubMed ID: 9431481
[TBL] [Abstract][Full Text] [Related]
32. Long-term study of recurrent vasospastic angina using coronary angiograms during ergonovine provocation tests.
Ozaki Y; Takatsu F; Osugi J; Sugiishi M; Watarai M; Anno T; Toyama J
Am Heart J; 1992 May; 123(5):1191-8. PubMed ID: 1575132
[TBL] [Abstract][Full Text] [Related]
33. Sequential spasm provocation tests might overcome a limitation of the standard spasm provocation tests.
Sueda S; Miyoshi T; Sasaki Y; Sakaue T; Habara H; Kohno H
Coron Artery Dis; 2015 Sep; 26(6):490-4. PubMed ID: 25974266
[TBL] [Abstract][Full Text] [Related]
34. [Chest pain of esophageal origin in patients with a normal coronary angiogram and ergonovine-induced coronary spasm].
Fournier JA; Trujillo L; Hernández MC; Fernández-Cortacero JA
Rev Esp Cardiol; 1993 Jan; 46(1):15-9. PubMed ID: 8430234
[TBL] [Abstract][Full Text] [Related]
35. [Coronary venous oxygen saturation dynamics during intracoronary infusion of ergonovine or acetylcholine in vasospastic angina].
Mikuniya A; Mikami M; Fujino Y; Higashiyama A; Murayama S; Onodera K; Kikuchi F; Sawai M; Akitsu H; Oikawa M
Kokyu To Junkan; 1991 May; 39(5):449-56. PubMed ID: 2068404
[TBL] [Abstract][Full Text] [Related]
36. Overview of the pharmacological spasm provocation test: Comparisons between acetylcholine and ergonovine.
Sueda S; Kohno H; Ochi T; Uraoka T; Tsunemitsu K
J Cardiol; 2017 Jan; 69(1):57-65. PubMed ID: 27856130
[TBL] [Abstract][Full Text] [Related]
37. [Reproducibility of spasm in patients with long-term remission of vasospastic angina by medical treatment].
Byun T; Uchida T; Hirosawa K; Mori F; Oomori H; Nagashima M; Enta K; Kodama S; Kasahara S; Iwade K; Hosoda S
J Cardiol; 1997 May; 29(5):243-50. PubMed ID: 9174879
[TBL] [Abstract][Full Text] [Related]
38. Coronary artery spasm as a frequent cause of acute coronary syndrome: The CASPAR (Coronary Artery Spasm in Patients With Acute Coronary Syndrome) Study.
Ong P; Athanasiadis A; Hill S; Vogelsberg H; Voehringer M; Sechtem U
J Am Coll Cardiol; 2008 Aug; 52(7):523-7. PubMed ID: 18687244
[TBL] [Abstract][Full Text] [Related]
39. Relationships between more than 90% coronary luminal narrowing induced by ergonovine provocation test and ECG ischemic change as well as chest symptoms.
Sueda S; Kohno H
Heart Vessels; 2018 Feb; 33(2):95-101. PubMed ID: 28808762
[TBL] [Abstract][Full Text] [Related]
40. [Ergometrine test in 1200 consecutive patients presenting with normal coronary vessels].
Bory M; Joly P; Bonnet JL; Djiane P; Serradimigni A
Arch Mal Coeur Vaiss; 1987 Jul; 80(8):1254-60. PubMed ID: 3120662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
